Uzbek scientists have created an edible COVID-19 vaccine synthesized from the common tomato called TOMAVAC, according to the Frontiers research journal website. According to the journal, the scientists inserted a fragment of …
The Ministry of Health of Azerbaijan, in connection with the alarming situation with increasing cases of measles, decided to carry out unscheduled vaccination of children whose parents had previously refused vaccination
A new coronavirus strain, BA.2.86 or Pirola, is more contagious compared to previous variants, the Russian Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing ( …
The Convasel and the MIR 19 vaccines are effective against the Arcturus coronavirus subvariant
Russia’s average share of people vaccinated against measles exceeds 95%, a spokesperson for the Federal Service for Surveillance on Consumer Rights Protection and Human Well-Being said. "The average share of …
The market size of the pharmaceuticals industry in Saudi Arabia reached $8.6 billion
Today it has become known that the Thai authorities will not introduce the entry requirement for foreign tourists, which was announced two days ago. The restriction, introduced amid the outbreak of COVID-19 in China, was formally in effect …
The shelf life of Russia-developed Sputnik V vaccine against coronavirus has been extended to 18 months, according to the state register of medicines. The extension applies to both components of the Sputnik V vaccine produced by the …
The specialists of the Russian Federal Medical-Biological Agency (FMBA) have developed a modern monkeypox vaccine, which is currently undergoing preclinical studies, the head of the FMBA, Veronika Skvortsova, said on Tuesday. "A …
The Russian Health Ministry has authorized the Smorodintsev Research Institute of Influenza operating under its aegis to begin clinical trials of the Corfluvec nasal vaccine for Covid-19 prophylaxis, according to information available in the …
The European Commission, via its Health Emergency Preparedness and Response Authority, signed a framework contract for the joint procurement of Adjupanrix, a pandemic influenza vaccine, with the pharmaceutical company GSK. …
Bavarian Nordic, the Danish company behind the vaccine being used to try to stem a global outbreak of monkeypox, is in talks to potentially expand production capacity, its CEO said. The Copenhagen-based vaccine maker has a vaccine that …
Covid vaccines prevented nearly 20 million deaths in the first year after they were introduced, according to the first large modelling study on the topic released Friday. The study, published in The Lancet Infectious Diseases, is based …
Russia’s Gamaleya Center plans to study immunity to monkeypox in people vaccinated against smallpox, the Center’s director, Alexander Gintsburg, said on Thursday. "We have been tasked to study the current …
The study showed that the vaccine is 97% effective when boosted with Sputnik Light or revaccinated with Sputnik V in cases of hospitalisation from the COVID-19 strain. A team of Russian scientists, including specialists from the …
Presenting proof of Covid vaccination and testing is no longer mandatory for foreign citizens entering Georgia starting today, following a decision by the Georgian Government. The latest amendments to the Government Resolution on …
An anti-coronavirus vaccine has been administered to 14 Russian children aged between 9 and 11 years as part of clinical trials, Director of the Gamaleya National Research Center for Epidemiology and Microbiology Alexander Gintsburg has told …
The number of new coronavirus cases remains quite high in Russia so people need to get booster vaccine shots, Health Minister Mikhail Murashko said. "The number of new cases remains quite high so we recommend that people get …
Venezuelan President Nicolas Maduro reported getting a booster dose of the Russian Sputnik Light vaccine against coronavirus on Thursday. "I received a booster dose, it was Sputnik Light, on the same day with Cecilia (his …
Third phase of clinical trials of Turkish coronavirus vaccine Turkovac continues in Azerbaijan, Baku Health Center said. "Third phase of clinical trials will last 15 months. There are those who wish to take part in them on a …
